Share to
Share to
Test ID:
PCNA
Proliferating-Cell Nuclear Antigen Antibodies (PCNA), Serum
Test Overview
Clinical Utility
Antibody to proliferating cell nuclear antigen (PCNA Ab) may be detected in a small subpopulation (3-5%) of SLE patients. They are highly SLE-specific and are associated with higher incidence of diffuse glomerulonephritis among SLE patients.
Method
Indirect Immunofluorescence Assay (IFA)
Result Included
Proliferating-Cell Nuclear Antigen Antibodies (PCNA)
Specimen
Specimen Type
SerumVolume
Sample Volume
1.0 mL
Minimum Volume
0.5 mL
Specimen Comment
Gel-separator tubes are acceptable.
Collection & Handling
Handling Information
Store and send frozen.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 4 days | 7 days | 30 days |
Rejection Criteria
| Criteria | Specification |
|---|---|
| Hemolysis | Gross |
| Lipemia | Present |
Performance & Interpretation
Turnaround Time
15 days
Results
Name
Units
Reference Range
Conversion
-
PCNA AntibodiesQualitative TestNegative
Referral Location
Out-of-Country
Test Version
Last Updated
2019-09-30